SyB L-0501
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for SyB L-0501, covering 2010-07-22 to 2023-04-18. Get the full timeline:
Most recent: Clinical Trial Update: Phase III Study of SyB L-0501 in Combination With Rituximab to Treat Recurrent/Relapsed Diffuse Large B-Cell Lymphoma [Phase 3]